ReviewJournal for immunotherapy of cancer2025

Preclinical ex vivo and in vivo models to study immunotherapy agents and their combinations as predictive tools toward the clinic.

Iñaki Eguren-Santamaria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.